ELHT Evidence Hub
  • Home
  • Meet the Team
  • Library Facilities
  • Education, Research and Innovation
Picture

Clinical outcomes of an ultra-thin strut sirolimus-eluting stent with biodegradable polymer in all-comers patients undergoing coronary intervention

20/12/2019

0 Comments

 
Author(s) Menown I.B.A.; De Silva R.; Mitra R.; Balachandran K.; More R. et al.
Source European Heart Journal; Oct 2019; vol. 40 ; p. 1744
Background: Thin stent struts may be associated with reduced vessel injury and use of biodegradable polymers may further improve long term outcomes. However, data with earlier stents has been inconsistent; thus further studies with newer devices are needed. Purpose(s): To evaluate the efficacy and safety of a new ultra-thin (65um) strut cobalt chromium sirolimus-eluting stent with a hybrid design (closed cell at ends and open cells in middle to reduce edge injury and optimise conformability) in all-comers patients undergoing percutaneous coronary intervention (PCI).

Method(s): We enrolled 752 patients from 14 sites undergoing PCI into a prospective, non-randomised, multi-centre, open-label, observational registry. Inclusion of patients with complex anatomy (long stent lengths, bifurcations and chronic total occlusions) was encouraged. Clinical follow-up was scheduled at 1, 9, 12 and 24 months. The primary endpoint was incidence of major adverse cardiac events (MACE)-cardiac death, non-fatal myocardial infarction (MI), or target vessel revascularization (TVR)-at 9 months.

​Result(s): Mean patient age was 64.7+/-12.2 years, 20.7% had diabetes, 58.8% had dyslipidaemia, 40.4% had multi-vessel disease, 22% had previous PCI, 4.7% had previous coronary-artery bypass graft, and 19.6% had a clinical history of previous MI. Mean lesion length was 25.7+/-17.3 mm. The primary endpoint of cumulative MACE up to 9 months (from 624 patients reaching 9 months follow-up) occurred in 12 patients (1.92%), including 6 (0.96%) cardiac death, 5 (0.80%) MI and 6 (0.96%) clinically indicated TVR. Definite stent thrombosis was reported in 3 patients (0.48%) and probable stent thrombosis in 2 patients (0.32%). Conclusion(s): Use of an ultra-thin strut biodegradable polymer sirolimuseluting stent in all-comers patients undergoing PCI was associated with good clinical efficacy and safety.
0 Comments



Leave a Reply.

    The following databases were searched:
    EMBASE,  MEDLINE, PsycINFO, BNI, CINAHL, 
    to find  ELHT staff publications

    Specialties

    All
    ANAESTHETICS
    CARDIOLOGY
    COVID 19
    DERMATOLOGY
    DIABETES
    DIETETICS
    EMERGENCY CARE
    GYNAECOLOGY
    MAXILLOFACIAL
    NEONATOLOGY
    OBSTETRICS
    ONCOLOGY
    ORTHOPAEDICS
    PAEDIATRICS
    PAIN
    PHARMACY
    RADIOLOGY
    RESPIRATORY
    SURGERY
    UROLOGY
    VASCULAR SURGERY

    RSS Feed

    Archives - past 2 years

    December 2020
    November 2020
    October 2020
    September 2020
    July 2020
    June 2020
    May 2020
    April 2020
    March 2020
    February 2020
    January 2020
    December 2019
    November 2019
    October 2019
    September 2019
    August 2019
    January 2019
    December 2018

Learning Centre Library
Royal Blackburn Teaching Hospital
library.blackburn@elht.nhs.uk
01254 734312 or Ext 84312

​Find us

Staffed Opening Hours
Mon      08:30-16:30
Tue       08:30-16:30
Wed     08:30-16:30
Thu      08:30-16:30
Fri         08:30-16:00
Mackenzie Library
Burnley General Teaching Hospital
library.burnley@elht.nhs.uk
01282 803114 or Ext. 13114

Find us

Staffed Opening Hours
Mon      08:30-16:00
Tue       08:30-16:00
Wed     08:30-16:00
Thu       08:30-16:00
Fri         Unstaffed

FAQS
​Library Catalogue
Library @lerts
​Your Specialty or Professional Group
Membership Terms & Conditions
Privacy Policy
Our Performance
​Your Feedback
​Specialty Journals

Picture
Picture
24/7 access to the library is available - please see library staff
Picture
  • Home
  • Meet the Team
  • Library Facilities
  • Education, Research and Innovation